Antipsychotic agents and cardiometabolic morbidity in youth.
Stefan P
SP
Kruszewski
Richard P
RP
Paczynski
D000293:Adolescent; D000367:Age Factors; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000453:epidemiology; D002648:Child; D003920:Diabetes Mellitus / Q000139:chemically induced / Q000453:epidemiology*; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D015994:Incidence; D007333:Insulin Resistance; D008297:Male; D009765:Obesity / Q000139:chemically induced / Q000453:epidemiology*; D018570:Risk Assessment; D012308:Risk Management
D014150:Antipsychotic Agents